{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:24:09Z","timestamp":1785165849509,"version":"3.55.0"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["NRPU-3766"],"award-info":[{"award-number":["NRPU-3766"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The rotenone-induced animal model of Parkinson\u2019s disease (PD) has been used to investigate the pathogenesis of PD. Oxidative stress is one of the main contributors of neurodegeneration in PD. Flavonoids have the potential to modulate neuronal function and combat various neurodegenerative diseases. The pre- and post-supplementation of quercetin (50 mg\/kg, p.o) was done in rats injected with rotenone (1.5 mg\/kg, s.c). After the treatment, behavioral activities were monitored for motor activity, depression-like behavior, and cognitive changes. Rats were decapitated after behavioral analysis and the brain samples were dissected out for neurochemical and biochemical estimation. Results showed that supplementation of quercetin significantly (<jats:italic>p<\/jats:italic>&lt;0.01) restored rotenone-induced motor and non-motor deficits (depression and cognitive impairments), enhanced antioxidant enzyme activities (<jats:italic>p<\/jats:italic>&lt;0.01), and attenuated neurotransmitter alterations (<jats:italic>p<\/jats:italic>&lt;0.01). It is suggested that quercetin supplementation improves neurotransmitter levels by mitigating oxidative stress via increasing antioxidant enzyme activity and hence improves motor activity, cognitive functions, and reduces depressive behavior. The results of the present study showed that quercetin pre-supplementation produced more significant results as compared to post-supplementation. These findings show that quercetin can be a potential therapeutic agent to reduce the risk and progression of PD.<\/jats:p>","DOI":"10.1371\/journal.pone.0258928","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:29:41Z","timestamp":1636741781000},"page":"e0258928","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity"],"prefix":"10.1371","volume":"16","author":[{"given":"Syeda","family":"Madiha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiqa","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laraib","family":"Liaquat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Sadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidrah","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwat","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0329-1125","authenticated-orcid":true,"given":"Saida","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"pone.0258928.ref001","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/ijerph8051402","article-title":"Pesticide exposure, safety issues, and risk assessment indicators","volume":"8","author":"C A Damalas","year":"2001","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0258928.ref002","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1007\/s11356-015-4596-2","article-title":"Short-term exposure to low doses of rotenone induces developmental, biochemical, behavioral, and histological changes in fish","volume":"22","author":"K M Melo","year":"2015","journal-title":"Environ Sci Pollut Res Int"},{"key":"pone.0258928.ref003","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"R Betarbet","year":"2000","journal-title":"Nature Neurosci"},{"key":"pone.0258928.ref004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuro.2016.11.006","article-title":"Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish","volume":"58","author":"Y Wang","year":"2017","journal-title":"Neurotoxicology"},{"key":"pone.0258928.ref005","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.20102","article-title":"Time to move beyond nigrostriatal dopamine deficiency in Parkinson\u2019s disease","volume":"55","author":"A E Lang","year":"2004","journal-title":"Ann Neurol"},{"key":"pone.0258928.ref006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.23609","article-title":"A critical appraisal of the premotor symptoms of Parkinson\u2019s disease: Potential usefulness in early diagnosis and design of neuroprotective trials","volume":"26","author":"A E Lang","year":"2011","journal-title":"Mov Disord"},{"key":"pone.0258928.ref007","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD Study)","volume":"30","author":"C Pont-Sunyer","year":"2015","journal-title":"Mov Disord"},{"key":"pone.0258928.ref008","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"J A Obeso","year":"2017","journal-title":"Mov Disord"},{"key":"pone.0258928.ref009","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"R M Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"pone.0258928.ref010","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"L H Morais","year":"2012","journal-title":"Pharmacol Rep"},{"key":"pone.0258928.ref011","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"W Dauer","year":"2003","journal-title":"Neuron"},{"key":"pone.0258928.ref012","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding dopaminergic cell death pathways in Parkinson disease","volume":"90","author":"P P Michel","year":"2016","journal-title":"Neuron"},{"key":"pone.0258928.ref013","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"J Langston","year":"1983","journal-title":"Science"},{"key":"pone.0258928.ref014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson\u2019s disease","volume":"31","author":"J T Greenamyre","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0258928.ref015","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.jalz.2014.04.014","article-title":"The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk","volume":"10","author":"C M Tanner","year":"2014","journal-title":"Alzheimers Dement"},{"key":"pone.0258928.ref016","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"G Pezzoli","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"pone.0258928.ref017","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/ijms20092313","article-title":"Natural Compounds for Alzheimer\u2019s disease therapy: a systematic review of preclinical and clinical studies","volume":"20","author":"S Andrade","year":"2019","journal-title":"Int J Mol Sciences"},{"issue":"3","key":"pone.0258928.ref018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570159X16666180911124605","article-title":"Neuroprotective Strategies for Neurological Disorders by Natural Products: An update","volume":"17","author":"M U Rehman","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"pone.0258928.ref019","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuint.2015.11.001","article-title":"Neurodegenerative diseases: from available treatments to prospective herbal therapy","volume":"95","author":"I Solanki","year":"2016","journal-title":"Neurochem Int"},{"key":"pone.0258928.ref020","first-page":"823206","article-title":"Cognitive-enhancing effect of quercetin in a rat model of Parkinson\u2019s disease induced by 6-hydroxydopamine","volume":"2012","author":"N Sriraksa","year":"2012","journal-title":"Evid Based Complement Alternt. Med"},{"key":"pone.0258928.ref021","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0278-6915(95)00077-1","article-title":"Review of the biology of quercetin and related bioflavonoid","volume":"33","author":"J V Formica","year":"1995","journal-title":"Food Chem. Toxicol"},{"key":"pone.0258928.ref022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1874609810801030169","article-title":"Nanoparticulated quercetin in combating age related cerebral oxidative injury","volume":"1","author":"S Das","year":"2008","journal-title":"Curr. Aging Sci"},{"key":"pone.0258928.ref023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2009.08.006","article-title":"Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer\u2019s disease relevant genes in mice","volume":"61","author":"P Huebbe","year":"2010","journal-title":"Pharmacol Res"},{"key":"pone.0258928.ref024","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.freeradbiomed.2011.06.017","article-title":"Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats","volume":"51","author":"A Ishisaka","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"pone.0258928.ref025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: from antioxidant to nutraceutical","volume":"585","author":"A W Boots","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"pone.0258928.ref026","doi-asserted-by":"crossref","first-page":"2986796","DOI":"10.1155\/2016\/2986796","article-title":"Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more","volume":"2016","author":"L G Costa","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"pone.0258928.ref027","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","article-title":"Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson\u2019s disease in rats","volume":"236","author":"S S Karuppagounder","year":"2013","journal-title":"Neuroscience"},{"key":"pone.0258928.ref028","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbt.21821","article-title":"Ameliorative effect of quercetin on neurochemical and behavioral deficits in rotenone rat model of Parkinson\u2019s disease: modulating autophagy (quercetin on experimental Parkinson\u2019s disease)","volume":"30","author":"H E El\u2010Horany","year":"2016","journal-title":"J Biochem Mol Toxicol"},{"key":"pone.0258928.ref029","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.physbeh.2012.04.024","article-title":"Effects of perinatal exposure to palatable diets on body weight and sensitivity to drugs of abuse in rats","volume":"107","author":"M E Bocarsly","year":"2012","journal-title":"Physiol Behav"},{"key":"pone.0258928.ref030","first-page":"943","article-title":"Assessment of gait dynamics in rotenone-induced rat model of Parkinson\u2019s disease by footprint method. Pak","volume":"30","author":"S Madiha","year":"2017","journal-title":"J. Pharm. Sci"},{"key":"pone.0258928.ref031","first-page":"53","article-title":"Memory enhancement and reduction in lipid peroxidation by dietary antioxidants in brain","volume":"49","author":"L Liaquat","year":"2016","journal-title":"Pak. J. Biochem. Mol. Biol"},{"key":"pone.0258928.ref032","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2017.12.034","article-title":"Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats","volume":"194","author":"L Liaquat","year":"2018","journal-title":"Life Sci"},{"key":"pone.0258928.ref033","first-page":"277","article-title":"A new method for the measurement of muscle relaxation in white mice","volume":"152","author":"W Kondziela","year":"1964","journal-title":"Arch Int Pharmacodyn. Ther"},{"key":"pone.0258928.ref034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pbb.2004.07.008","article-title":"Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion","volume":"79","author":"U Yanpallewar S","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"pone.0258928.ref035","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.21180","article-title":"Brain edema and inflammatory activation in bile duct ligated rats and diet-induced hyperammonemia: A model of Hepatic encephalopathy in cirrhosis","volume":"43","author":"R Jover","year":"2006","journal-title":"Hepatology"},{"key":"pone.0258928.ref036","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2007.04.007","article-title":"Reversal of haloperidol-induced VCMs and supersensitive somatodendritic serotonergic response by buspirone in rats","volume":"87","author":"D J Haleem","year":"2007","journal-title":"Pharmacol. Biochem. Behav"},{"key":"pone.0258928.ref037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00421964","article-title":"On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity","volume":"34","author":"B Costall","year":"1974","journal-title":"Psychopharmacologia"},{"key":"pone.0258928.ref038","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.17582\/journal.pjz\/2018.50.4.1245.1256","article-title":"Therapeutic effects of curcuma longa against rotenone-induced gross motor skills deficits in rats","volume":"50","author":"S Madiha","year":"2018","journal-title":"Pak. J. Zool"},{"key":"pone.0258928.ref039","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awt144","article-title":"Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease","volume":"136","author":"I Nascimento-Ferreira","year":"2013","journal-title":"Brain"},{"key":"pone.0258928.ref040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11011-018-0352-x","article-title":"Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test","volume":"34","author":"S Madiha","year":"2019","journal-title":"Metab. Brain Dis"},{"key":"pone.0258928.ref041","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.npp.1300722","article-title":"Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin","volume":"30","author":"PR Lee","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"pone.0258928.ref042","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yebeh.2007.02.001","article-title":"Kindling epileptogenesis in immature rats leads to persistent depressive behavior","volume":"10","author":"A Mazarati","year":"2007","journal-title":"Epilepsy Behav"},{"key":"pone.0258928.ref043","first-page":"47","article-title":"A new one-trial test for neurobiological studies of memory in rats","volume":"31","author":"A Ennaceur","year":"1988","journal-title":"1: Behavioral data. Behav. Brain Res"},{"key":"pone.0258928.ref044","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresbull.2016.10.002","article-title":"Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: a comparative study","volume":"127","author":"S Haider","year":"2016","journal-title":"Brain Res. Bull"},{"issue":"4","key":"pone.0258928.ref045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","article-title":"Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels","volume":"167","author":"B K Goulart","year":"2010","journal-title":"Neuroscience"},{"issue":"15","key":"pone.0258928.ref046","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss","volume":"33","author":"M Cohen R","year":"2013","journal-title":"J. Neurosci"},{"issue":"1","key":"pone.0258928.ref047","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12906-017-1652-0","article-title":"Withania somnifera leaf alleviates cognitive dysfunction by enhancing hippocampal plasticity in high fat diet induced obesity model","volume":"17","author":"S Manchanda","year":"2017","journal-title":"BMC complementary and alternative medicine"},{"key":"pone.0258928.ref048","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/319774a0","article-title":"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5","volume":"319","author":"R G Morris","year":"1986","journal-title":"Nature"},{"key":"pone.0258928.ref049","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainresbull.2015.11.001","article-title":"Repeated administration of almonds increases brain acetylcholine levels and enhances memory function in healthy rats while attenuates memory deficits in animal model of amnesia","volume":"120","author":"Z Batool","year":"2016","journal-title":"Brain Res. Bull"},{"key":"pone.0258928.ref050","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11357-014-9653-0","article-title":"Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system","volume":"36","author":"S Haider","year":"2014","journal-title":"Age (Dordr.)"},{"key":"pone.0258928.ref051","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF02533017","article-title":"An enzymatic protective mechanism against lipid peroxidation damage to lungs of ozone-exposed rats","volume":"7","author":"K Chow C","year":"1971","journal-title":"Lipids"},{"issue":"5","key":"pone.0258928.ref052","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007691-200110000-00008","article-title":"Glutathione stability in whole blood: effects of various deproteinizing acids","volume":"23","author":"D Stempak","year":"2001","journal-title":"Therapeutic drug monitoring"},{"key":"pone.0258928.ref053","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1021\/jf0255735","article-title":"Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models","volume":"50","author":"K N Chidambara Murthy","year":"2002","journal-title":"J. Agric. Food Chem"},{"key":"pone.0258928.ref054","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","article-title":"Assays of glutathione peroxidase","volume":"105","author":"L Flohe","year":"1984","journal-title":"Methods Enzymol"},{"key":"pone.0258928.ref055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-2697(72)90132-7","article-title":"Colorimetric assay of catalase","volume":"4","author":"AK Sinha","year":"1972","journal-title":"Anal Biochem"},{"key":"pone.0258928.ref056","first-page":"1","article-title":"Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase","volume":"24","author":"H Nagata","year":"1999","journal-title":"Tokai J Exp Clin Med"},{"key":"pone.0258928.ref057","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2011.11.021","article-title":"Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP\/probenecid induced Parkinson\u2019s disease","volume":"1433","author":"A Anandhan","year":"2012","journal-title":"Brain Res"},{"key":"pone.0258928.ref058","doi-asserted-by":"crossref","first-page":"314560","DOI":"10.1155\/2015\/314560","article-title":"Protective mechanisms of flavonoids in Parkinson\u2019s disease","volume":"2015","author":"K B Magalingam","year":"2015","journal-title":"Oxid. Med. Cell. longev"},{"key":"pone.0258928.ref059","first-page":"928643","article-title":"Effect of quercetin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of","volume":"2012","author":"C Lv","year":"2012","journal-title":"Parkinson\u2019s disease. Evid Based Complement Alternt. Med"},{"key":"pone.0258928.ref060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nn941","article-title":"Neuroprotective and neurorestorative strategies for Parkinson\u2019s disease","volume":"5","author":"T M Dawson","year":"2002","journal-title":"Nat. Neurosci"},{"issue":"1","key":"pone.0258928.ref061","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"M Alam","year":"2002","journal-title":"Behav. Brain Res"},{"key":"pone.0258928.ref062","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"C Guo","year":"2013","journal-title":"Neural Regen Res"},{"key":"pone.0258928.ref063","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4103\/1673-5374.211194","article-title":"Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"S Singh","year":"2017","journal-title":"Neural. Regen. Res"},{"issue":"2","key":"pone.0258928.ref064","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"J R Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"key":"pone.0258928.ref065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12263-008-0091-4","article-title":"The neuroprotective potential of flavonoids: a multiplicity of effects","volume":"3","author":"D Vauzour","year":"2008","journal-title":"Genes Nutr"},{"issue":"2","key":"pone.0258928.ref066","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium\/GSK3\u03b2 pathway","volume":"233","author":"YH Yuan","year":"2015","journal-title":"Toxicol, Lett"},{"issue":"19","key":"pone.0258928.ref067","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of alpha-synuclein filament assembly","volume":"45","author":"M Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"pone.0258928.ref068","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnagi.2020.00004","article-title":"Strategies for the treatment of Parkinson\u2019s disease: beyond dopamine","volume":"12","author":"A Iarkov","journal-title":"Front. Aging Neurosci. 2020"},{"issue":"10","key":"pone.0258928.ref069","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ejn.13638","article-title":"Striatal cholinergic interneurons and Parkinson\u2019s disease","volume":"47","author":"A Tanimura","year":"2018","journal-title":"Eur. J. Neurosci"},{"issue":"8","key":"pone.0258928.ref070","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/mds.26300","article-title":"Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease","volume":"30","author":"M Deffains","year":"2015","journal-title":"Mov Disord"},{"issue":"2","key":"pone.0258928.ref071","first-page":"564","article-title":"The cholinergic system and Parkinson disease.Behav","volume":"221","author":"N I Bohnen","year":"2011","journal-title":"Brain Res"},{"key":"pone.0258928.ref072","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"K R Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"pone.0258928.ref073","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/mds.20362","article-title":"Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson\u2019s disease","volume":"20","author":"J E Ahlskog","year":"2005","journal-title":"Mov Disord"},{"key":"pone.0258928.ref074","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","article-title":"Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson\u2019s disease","volume":"36","author":"H Kaur","year":"2001","journal-title":"Neurochem. Res"},{"key":"pone.0258928.ref075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/109662003772519976","article-title":"Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice","author":"M Anjaneyulu","year":"2003","journal-title":"J. Med. Food"},{"key":"pone.0258928.ref076","doi-asserted-by":"crossref","first-page":"2963565","DOI":"10.1155\/2018\/2963565","article-title":"Advances in the preclinical study of some flavonoids as potential antidepressant agents","volume":"2018","author":"L J German-Ponciano","year":"2018","journal-title":"Scientifica"},{"key":"pone.0258928.ref077","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.nut.2010.09.002","article-title":"Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria","volume":"27","author":"S Yoshino","year":"2011","journal-title":"Nutrition"},{"key":"pone.0258928.ref078","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jalz.2013.12.005","article-title":"Exenatide as a potential treatment for patients with Parkinson\u2019s disease: first steps into the clinic","volume":"10","author":"T Foltynie","year":"2014","journal-title":"Alzheimers Dement"},{"key":"pone.0258928.ref079","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA-and MPTP-lesioned rats as models of the early phase of Parkinson\u2019s disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"M M Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"pone.0258928.ref080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2008.129","article-title":"Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson\u2019s disease","volume":"34","author":"E De Leonibus","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"pone.0258928.ref081","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biom10010059","article-title":"Neuroprotective Effects of Quercetin in Alzheimer\u2019s Disease","volume":"10","author":"H Khan","year":"2019","journal-title":"Biomolecules"},{"key":"pone.0258928.ref082","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"\u0160 \u0160trac D","year":"2016","journal-title":"Transl. Neurosci"},{"key":"pone.0258928.ref083","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson\u2019s disease as a function of dopaminergic medication and task demands","volume":"11","author":"R Cools","year":"2001","journal-title":"Cereb. Cortex"},{"issue":"12","key":"pone.0258928.ref084","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/aje\/kwm036","article-title":"Flavonoid intake and cognitive decline over a 10-year period","volume":"165","author":"L Letenneur","year":"2007","journal-title":"Am. J. Epidemiol"},{"issue":"8","key":"pone.0258928.ref085","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/01.wnl.0000240224.38978.d8","article-title":"Associations of vegetable and fruit consumption with age-related cognitive change","volume":"67","author":"MC Morris","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"pone.0258928.ref086","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.amjmed.2006.03.045","article-title":"Fruit and vegetable juices and Alzheimer\u2019s disease: the Kame Project","volume":"119","author":"Q Dai","year":"2006","journal-title":"Am. J. Med"},{"issue":"8","key":"pone.0258928.ref087","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/155.8.732","article-title":"Parkinson\u2019s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake","volume":"155","author":"H Checkoway","year":"2002","journal-title":"Am. J. Epidemiol"},{"key":"pone.0258928.ref088","doi-asserted-by":"crossref","first-page":"891748","DOI":"10.1155\/2013\/891748","article-title":"Polyphenols: multipotent therapeutic agents in neurodegenerative diseases","volume":"2013","author":"KS Bhullar","year":"2013","journal-title":"Oxid. Med. Cell. Longev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:30:43Z","timestamp":1636741843000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258928"}},"subtitle":[],"editor":[{"given":"David I","family":"Finkelstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0258928","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}